A concept for trial institutions focussing on randomised controlled trials in surgery by Rahbari, Nuh N et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Trials
Open Access Methodology
A concept for trial institutions focussing on randomised controlled 
trials in surgery
Nuh N Rahbari, Markus K Diener, Lars Fischer, Moritz N Wente, Peter Kienle, 
Markus W Büchler and Christoph M Seiler*
Address: Department of General, Visceral and Trauma Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany
Email: Nuh N Rahbari - nuh.rahbari@med.uni-heidelberg.de; Markus K Diener - markus.diener@med.uni-heidelberg.de; 
Lars Fischer - lars.fischer@med.uni-heidelberg.de; Moritz N Wente - moritz.wente@med.uni-heidelberg.de; 
Peter Kienle - Peter.Kienle@chir.ma.uni-heidelberg.de; Markus W Büchler - markus.buechler@med.uni-heidelberg.de; 
Christoph M Seiler* - christoph.seiler@med.uni-heidelberg.de
* Corresponding author    
Abstract
Background: Although considered the reference standard for generating valid scientific evidence
of a treatment's benefits and harms, the number of Randomised Controlled Trials (RCT) comparing
surgical techniques remains low. Much effort has been made in order to overcome methodological
issues and improve quality of RCTs in surgery. To the present there has been, however, only little
emphasis on development and maintenance of institutions for implementation of adequately
designed and conducted surgical RCTs.
Mehods/Design: Description of the developments in surgical RCT infrastructure in Germany
between 2001 and 2006. Cross sectional evaluation of completed and ongoing surgical RCTs within
the German Surgical Society and the Clinical Study Centre, Department of Surgery, University of
Heidelberg.
Results: Foundation of a national Clinical Trial Centre (CTC) for the organisation of multi-centre
RCTs in the surgical setting (Study Center of the German Surgical Society, SDGC). Establishment
of a network of CTCs with affiliated Clinical Sites (CSs) to enhance patient recruitment and shorten
the duration of RCTs. Since its foundation four surgical RCTs with a total sample size of 1650
patients (1006 of these randomised) have been supervised by the SDGC with 35 CSs involved in
patient recruitment. Five further CTCs were set up in 2006. Together with their affiliated CSs a
network has been organised providing improved conditions for the conduction of surgical RCTs.
Conclusion:  Improvement of infrastructure substantially facilitates integration of RCTs into
routine surgical practice. A network of collaborating CTCs and CSs can provide an adequate
infrastructure for the conduction of multi-centre RCTs.
Background
Randomised Controlled Trials (RCT) are considered the
reference standard for generating valid scientific evidence
on benefits and harms of treatments in surgery [1]. How-
ever, the percentage of RCTs dealing with surgical inter-
ventions is still low. A Medline analysis revealed that only
about 15% of all published RCTs were conducted in the
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surgical setting [2]. It is estimated that only 24% of surgi-
cal therapies are based on the results of RCTs [3].
There are considerable national differences in the extent
to which surgical RCTs (sRCTs) are pursued. In the United
States the American College of Surgeons Oncology Group
(ACOSOG) was founded in 1996 and is funded by the
National Cancer Institute in order to increase the quantity
and quality of sRCTs [4]. In Europe, the number of RCTs
(adjusted for population size) conducted in the United
Kingdom and the Netherlands is substantially higher than
in most other European countries, with Germany lagging
far behind [5]. Furthermore, the number of sRCTs in the
leading German surgical journal "Der Chirurg" have
decreased since 2000, while the corresponding number of
sRCTs in international surgical journals has remained
constant [6]. Although the German Science Council
already recognised a lack of patient-oriented clinical
research in Germany in the early 1990s, major national
problems, i.e. lack of funding and a weak infrastructure
for the implementation of surgical trials, were still present
in 2003 [7]. However, within the last few years much
effort has been invested into forming a working national
infrastructure in surgical departments and the German
Surgical Society (Deutsche Gesellschaft für Chirurgie) in
order to establish an environment in which high-quality
sRCTs can be performed on a larger scale.
The objective of this article is to describe recent develop-
ments in surgical trial infrastructure in Germany provid-
ing a sketch of how trial institutions for sRCTs might be
organised. It's outline follows a previously proposed
structure for reports dealing with quality improvement in
health care [8].
The problem
RCTs in surgery comprise several challenges regarding
methodology (difficulties with standardisation and blind-
ing), ethics (correct timing of sRCTs, clinical equipoise,
and placebo surgery), surgeons (scepticism to randomise
patients, lack of methodological expertise and time), and
patients (preference for less invasive procedures, reluc-
tance to be randomised to different surgical procedures)
[1,9]. Therefore increasing the quantity and quality of
sRCTs is a complex task requiring both a working infra-
structure and sufficient funding.
Key measures for improvement
A dual concept has been developed consisting of a Clini-
cal Trial Centre (CTC), responsible for planning, conduc-
tion (management), and analysis of multi-centre sRCTs
and of Clinical Sites (CS), which primarily focus on
recruitment and treatment of study patients in accordance
with Good Clinical Practice (GCP) guidelines [10]. The
effectiveness of this approach can be evaluated quantita-
tively at the CTC level according to the number of per-
formed multi-centre sRCTs, the number of recruited CSs,
and the foundation of additional CTCs. In addition to
these quantitative measures, established processes are
evaluated qualitatively (e.g. the extent of collaborations
with different scientific institutions and the adherence to
the principles of GCP). Similarily, CSs are evaluated by
the number and spectrum of conducted trials, the number
of included patients, and the extent of cooperations.
Gathering information and strategies for change
Clinical Trial Centre (CTC)
The development of a national CTC for multi-centre
sRCTs was based on several meetings of the German Sur-
gical Society's Steering Committee and a visit to ACO-
SOG. This visit was accompanied by representatives of
the German Federal Ministry of Education and Research
which constitutes the central national body for institu-
tional grants and regularly announces new programs for
the medical sciences. As a result thereof the German Sur-
gical Society commissioned the Department of Surgery at
the University of Heidelberg to apply for a grant in 2003
in order to establish the Study Centre of the German Sur-
gical Society [Studienzentrum der Deutschen Gesellschaft
für Chirurgie (SDGC)]. This decision was based on the
pre-existing facilities for surgical trials and local expertise
at the University of Heidelberg, including a well estab-
lished Institute for Biometrics and a centre for clinical tri-
als (see below). The aim of the SDGC is to provide
services to surgeons intending to initiate or participate in
multi-centre sRCTs. The tasks of the SDGC include: selec-
tion of trial ideas and study development, fund raising,
registration of trials, compliance with legal requirements,
ethical review management, conduction and analysis of
trials, selection, monitoring, and auditing of CSs, quality
assurance, education, and publication. An organisational
structure was set up for the SDGC consisting of boards
and units that involve representatives of the German Sur-
gical Society and the Medical Faculty of the University of
Heidelberg [9]. In order to properly address all relevant
aspects of sRCTs, an interdisciplinary team (n = 12) con-
sisting of surgeons trained in clinical trials, biometri-
cians, study nurses, clinical research associates, data
managers, monitors, and administrative people was
formed. Furthermore, collaborations with relevant insti-
tutions were initiated, such as with the German Cochrane
Centre for systematic reviews and meta-analysis (plan-
ning of trials) and the Coordinating Centres for Clinical
Trials Network. Trial ideas can be submitted via the
SDGC homepage and subsequently run through a four-
step selection process which for approved studies ulti-
mately results in a finalised study protocol. The SDGC
prioritises study ideas following the FINER criteria: feasi-
ble, interesting, novel, ethical, relevant. A detailed
description of the process with further details on studyTrials 2008, 9:3 http://www.trialsjournal.com/content/9/1/3
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selection and protocol design was published by the
SDGC [11].
The SDGC's CSs were formed based on the results of a
nationwide survey of surgical departments during which
237 of 1274 departments expressed their willingness to
participate in clinical trials.
The German Federal Ministry of Education and Research
approved the grant to the SDGC after external peer review
and funding started in 2005 for a period of six years. Addi-
tional funding was provided by the German Surgical Soci-
ety and industrial partners (Ethicon, Tyco Healthcare, and
Aesculap).
Clinical Sites (CS)
CSs provide access to patient populations. During multi-
centre surgical trials, the duties of CSs comprise screening
of patients for eligibility to be included in ongoing trials
based on predefined inclusion criteria, informing and
obtaining informed consent of patients, and treatment of
patients according to a study protocol and to GCP. The
Centre for Clinical Studies [Klinisches Studienzentrum
Chirurgie (KSC)] at the Department of Surgery at the Uni-
versity of Heidelberg provides an example of how a CS
can be set up [12]. The KSC was already founded in Octo-
ber 2001 with the intention of performing surgical trials
in a standardised fashion and to increase the number of
patients participating in surgical trials. After the recruit-
ment of professional personnel (two surgeons, three
study nurses, and a study secretary), the first patient was
recruited into a sRCT in May 2002. Subsequently, a net-
work between the Central Patient Management, responsi-
ble for all admissions to the Department of Surgery [13],
the local ethics committee, and the hospital administra-
tion was established. This network ensures high effi-
Table 1: Features of single-centre sRCTs (KSC) and multi-centre sRCTs (SDGC) (09/2007)
Trial/ISRCTN Interventions Primary Endpoint Sample size/Randomised 
patients/Clinical Sites
KSC BEGER/BERN 50638764 [17] Beger vs Berne procedure 
for surgical treatment of 
chronic pancreatitis
Duration of surgery
Quality of life
Time at ICU
Duration of hospital stay
65/65
POUCH 78983587 Transverse Coloplasty 
versus J-Pouch for low 
anterior rectal resection
Difficulties with evacuation after 2 years 150/150
POVATI 60734227 [18] Midline vs transverse 
laparotomy
Pain and use of analgesics 200/200
LAPCON-POUCH 61411448 [19] Laparoscopic vs. open total 
proctocolectomy with ileo-
anal pouch anastomosis
Blood loss
Units packed cells
130/30
PORTAS 52368201 [20] Venae Sectio vs. modified 
Seldinger Technique for 
Totally Implantable Access 
Ports
Primary success rate of surgical 
technique
164/164
SDGC INSECT 24023541 [14] Running vs interrupted 
fascia closure after midline 
laparotomy
Incisional hernia 600/624/25
CLIVIT 96901396 [15] Clips vs ligation in thyroid 
surgery
Duration of surgery 400/265/5
DISPACT 18452029 Stapling vs scalpel 
transsection and hand-
suture for distal 
pancreatectomy
Pancreatic fistula and mortality 550/101/25
TOPAR-PILOT 86202793 [21] Autotransplantation vs 
none after total 
parathyroidectomy
Recurrence of secondary 
hyperparathyroidism
100/16/7
ISRCTN = International Standard Randomised Controlled Trial Number http://www.controlled-trials.com
BEGER/BERN Duodenum preserving pancreatectomy in chronic pancreatitis: A randomised controlled trial comparing two surgical techniques; 
POUCH Colon J-Pouch versus Transverse Coloplasty Pouch after low anterior resection for rectal cancer: a randomised controlled trial; POVATI 
Postsurgical pain outcome of vertical and transverse abdominal incision – A randomised controlled equivalence trial; PORTAS Comparison of Venae 
Sectio vs. modified Seldinger Technique for Totally Implantable Access Ports; LAPCON-POUCH Totally laparoscopic vs conventional ileo-anal pouch 
procedure – design of a single-centre, expertise based randomised controlled trial to compare the laparoscopic and conventional surgical approach 
in patients undergoing primary elective restorative proctocolectomy; INSECT Interrupted vs continuous slowly absorbable sutures – evaluation of 
abdominal closure techniques; CLIVIT Clips vs ligature in thyroid surgery – a randomised controlled trial; DISPACT Distal pancreatectomy – A 
randomised controlled trial to compare to different surgical techniques; TOPAR-Pilot Secondary hyperparathyroidism: does total parathyroidectomy 
alone lead to lower rate of recurrence than total parathyroidectomy with autotransplantation? – A randomised controlled pilot trial.Trials 2008, 9:3 http://www.trialsjournal.com/content/9/1/3
Page 4 of 6
(page number not for citation purposes)
ciency in patient recruitment and treatment according to
GCP as all patients admitted to the Department of Sur-
gery are screened for eligibility for ongoing trials. Further-
more, time intervals for ethics approvals and finalising
contracts could be substantially shortened. Recruitment
of study patients was further facilitated by arranging for
an on-call service which allows recruitment of patients at
all times and is thus particularly helpful for the imple-
mentation of emergency trials. In order to ease funding
constraints for surgical trials pharmacological studies
were also pursued at the KSC. Moreover, pharmaceutical
trials provide valuable experience and serve as examples
for the design of high-quality surgical and investigator
driven trials. As a CS of the SDGC the KSC participates in
all multi-centre sRCTs, in addition to the single-centre
sRCTs it performs.
Effects of change
Clinical Trial Centers
Four multi-centre RCTs comparing surgical interventions
(total sample size: 1650) have been initiated (open to
patient recruitment) by the SDGC since 2004 (Table 1).
The first trial (INSECT – interrupted versus continuous
slowly absorbable sutures – evaluation of abdominal clo-
sure techniques) finished patient recruitment (n = 624) in
October 2006. All study protocols were registered and
have either been published or submitted for publication
[14,15]. The number of CSs recruited and initiated for the
SDGC's multi-centre sRCTs has now increased to 35. Two
positions were created at the SDGC in order to teach sur-
gical residents the methods of clinical research and epide-
miology. In addition, a professional education program
for surgeons in trials was successfully established, and the
results of the participant evaluation published [16].
The number of multi-centre sRCTs and the time needed to
accomplish the trials are highly dependent on the number
of participating CTCs and the resources available. Based
on the work of the SDGC which showed that it was feasi-
ble to integrate implementation of multi-centre trials into
the clinical routine of surgical departments, if properly
organised, a further grant program was announced by the
German Federal Ministry for Education and Research in
2005 in order to support the installation of additional sur-
gical CTCs. Surgical Departments of 22 Medical Faculties
applied and five were selected after external peer review
(Figure 1). In 2006 these five surgical CTCs and the SDGC
formed the German Surgical Trial Network [Chirurgisches
Netzwerk für operative Studien (CHIR-NET)]. Based on
the requirement to cooperate with local academic institu-
tions experienced in biometrics or clinical epidemiology
CTCs of the CHIR-NET are supposed to design and coor-
dinate multi-centre sRCTs which in turn will be supported
by all members of the network. In addition each CTC
cooperates with several CSs providing excellent access to
patients. Training and education of study personnel and
surgical residents is an additional joint task of the CHIR-
NET's CTCs. As a result of this collaboration six large trial
protocols have been submitted to the joint grant program
for multi-centre RCTs of the German Research Founda-
tion and the German Federal Ministry of Education and
Research in November 2006.
Clinical Trial Centres involved in the German Surgical Trial  Network (CHIR-NET) Figure 1
Clinical Trial Centres involved in the German Surgical Trial 
Network (CHIR-NET).
Table 2: Current number of studies and study patients at the Clinical Study Centre Heidelberg (09/2007)
Study type Number of studies Patients included Patients randomised
Surgical RCTs 15 1277 1022
Pharmaceutical studies (Phase I – IV) 30 880 771
Observational studies 4 405 *
Total 49 2601 1793
* No randomisation is performed in observational studiesTrials 2008, 9:3 http://www.trialsjournal.com/content/9/1/3
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Clinical Sites
Since its foundation in 2001, 25 clinical studies were suc-
cessfully completed at the KSC (five surgical, two observa-
tional and 18 pharmaceutical studies). Currently, 24
clinical studies are supervised by the KSC (ten surgical,
two observational and 12 pharmaceutical studies). To
date, more than 1700 patients have been randomised and
treated according to study protocols (Table 2). Five single-
centre sRCTs have been set up, registered, and four out of
five study protocols were published (Table 1) [17-20].
Results for the primary endpoint of three trials (Beger/
Bern, POVATI, PORTAS) will be available in 2008.
Table 3 gives an overview of key issues to be considered
for organisation of CTCs and CSs based on the knowledge
acquired by the SDGC and KSC during the last years. The
different mentioned aspects should be addressed via spe-
cific Standardized Operating Procedures.
Conclusion
The quantitiy and quality of sRCTs are substantially
dependent on a functional trial infrastructure. The devel-
opments in Germany demonstrate that the concept of
cooperating CTCs and CSs is a promising approach. Sur-
gical departments are able to conduct sRCTs according to
GCP guidelines within daily clinical routine, if they set up
a CS staffed with at least one study nurse and one study
surgeon. Furthermore, multi-centre sRCTs can be per-
formed if collaboration of CTCs and CSs is institutional-
ised and the relevant scientific organisations are involved.
Last but not least funding is an essential factor required
for establishment of adequate infrastructure and the
implementation of the projects. Consolidation and
growth of the established institutions and network sup-
ported by sufficient funding will be essential for sustaina-
ble increase of sRCTs. In times of limited human recourses
and financial constraints international collaborations will
be a further step forward in order to enhance multi-centre
sRCTs. The established trial infrastructure must not only
ensure proper preparation and implementation of sRCTs,
but also educate surgeons adequately about the principles
of clinical trials.
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Table 3: Key issues to be considered for organisation of Clinical trial Centres (CTC) and Clinical Sites (CS).
Clinical Trial Centre (CTC) Clinical Site (CS)
Study selection ￿ Evaluation and decision making by transparent 
process according to FINER-Criteria [11]
F Feasible
I Interesting
N Novel
E Ethical
R Relevant
￿ Funding sources avaliable
￿ How many eligible patients can I get? (approx. 10 patients 
per year and trial are recommended)
￿ Does the case money cover all costs?
￿ Are the proposed interventions feasible at the institution?
￿ Can patients be followed up according to the protocol?
Study conduction ￿ Adequate recruiting of CS (prior trial experience, 
sufficient patient populations)
￿ Continuous supervision of Clinical Sites performance 
(e.g. monitoring, auditing)
￿ Meetings prior to start of patient recruitment
￿ Training of participating surgeons in methods of 
clinical Trials
￿ Standardized enrollment process (i.e. screening of all 
admitted patients, informed consent, randomisation)
￿ Adherence to the study interventionsl and the national and 
international guidelines (e.g. GCP, Declaration of Helsinki)
￿ Organization of follow up and documentation
￿ Controlling of recruitment, treatment, and financial 
procedures
Networks and Partners ￿ Scientific societies
￿ Governmental authorities (e.g. FDA)
￿ National and international experts in trial 
methodology and the individual speciality
￿ Funding organisations
￿ Ethics committee
￿ Administration (contracts)
￿ Departments collaborating in treatment of patients (e.g. 
anaesthesiology, radiology)
￿ Institutions involved in required tests or delivery of study 
materials (e.g. laboratory, pharmacy)
￿ IT Infrastructure
Required human resources ￿ Principal Investigator
￿ Project manager
￿ Biostatistician
￿ Data manager
￿ Monitor
￿ Quality Assurance agent
￿ IT Manager
￿ Administrative agent
￿ Study physician
￿ Study nursePublish with BioMed Central    and   every 
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